#Japan #Tokyo #cancer detection #AI Diagnosis #MedBank Corp

MedBank Corporation Advances AI Diagnostic Tools

MedBank Corporation, headquartered in Chuo, Tokyo and led by CEO Lee Myung Chul, has announced the completion of two revolutionary AI systems aimed at dramatically enhancing the early detection and diagnostic accuracy of cancers. The two innovative systems include:

• - Ultrasound Thyroid Nodule Imaging Diagnostic AI Support System
• - Pathological Lung Cancer Diagnostic AI Support System

Both systems are targeted for practical utilization by the year 2026, with preparations now underway for submission to the Pharmaceuticals and Medical Devices Agency (PMDA).

Overview and Features

These systems serve as diagnostic support tools that enable AI to quickly analyze and differentiate ultrasound or pathological images in clinical settings. This instant analysis significantly reduces diagnostic time while alleviating the burden on physicians.

The Ultrasound Thyroid Nodule Imaging Diagnostic AI Support System is specifically designed to prevent the oversight of nodules with a high risk of malignancy. It utilizes high-precision annotated data provided by specialists, ensuring that the algorithm is tailored to real clinical environments.

On the other hand, the Pathological Lung Cancer Diagnostic AI Support System automatically classifies and evaluates pathological slide images of lung cancer through AI analysis. Developed in collaboration with Juntendo University Hospital, this system is equipped with a high-precision model based on actual clinical pathological data. It aims to facilitate faster diagnoses, address the shortage of pathologists, and optimize healthcare resources by anticipating double-checks by physicians.

Future Prospects

Looking ahead, MedBank is planning several expansions to diversify its offerings:

• - Application of AI medical imaging technology across all cancer types
• - Acceleration of overseas deployment with multilingual support (English, Chinese, Korean, etc.)
• - Development of a cloud-based AI diagnostic support platform

Strategic Partnership and Capital Collaboration

MedBank Corporation is actively seeking to build strategic partnerships with venture capitalists, corporate venture capital, and business enterprises. The company is eager to collaborate with investors and organizations interested in the cutting-edge technology of medical AI. Anyone invested in the advancements of the medical AI field is encouraged to explore potential partnerships with MedBank.

As a pioneer in the medical AI sector, MedBank Corporation continues to drive technological innovation, pushing the boundaries of what is possible to contribute to the medical field effectively.

Contact Information

For more inquiries, please reach out to the MedBank public relations department at [email protected].